InsidersTradesSigma
Browse the detailed record of transactions filed by Pomerantz Roger, Director. Officer active across 2 companies, notably Viracta Therapeutics, Inc.. In total, 4 filings have been recorded. The latest transaction was filed on 25 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Roger Pomerantz is a Director at Viracta Therapeutics, Inc. He oversees the company's activities and participates in strategic decision-making. His expertise in the biotechnology field allows him to make significant contributions to the company's governance.